ATE74750T1 - Schutzmittel fuer augenzubereitungen. - Google Patents

Schutzmittel fuer augenzubereitungen.

Info

Publication number: ATE74750T1
Authority: AT; Austria
Prior art keywords: protective agents; eye; caused; drug; eye preparations
Prior art date: 1987-09-11

Application number

AT88114804T

Other languages

English (en)

Inventor

Fu Cherng-Chyi Roger

Deborah M Lidgate

Original Assignee

Syntex Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-11

Filing date

1988-09-09

Publication date

1992-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22256043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE74750(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-09-09 Application filed by Syntex Inc filed Critical Syntex Inc

1992-05-15 Application granted granted Critical

1992-05-15 Publication of ATE74750T1 publication Critical patent/ATE74750T1/de

Links

238000002360 preparation method Methods 0.000 title 1
239000003223 protective agent Substances 0.000 title 1
239000003814 drug Substances 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000003755 preservative agent Substances 0.000 abstract 2
230000002335 preservative effect Effects 0.000 abstract 2
206010010741 Conjunctivitis Diseases 0.000 abstract 1
206010058202 Cystoid macular oedema Diseases 0.000 abstract 1
206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
208000020564 Eye injury Diseases 0.000 abstract 1
208000010412 Glaucoma Diseases 0.000 abstract 1
208000001344 Macular Edema Diseases 0.000 abstract 1
206010046851 Uveitis Diseases 0.000 abstract 1
239000008135 aqueous vehicle Substances 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
201000010206 cystoid macular edema Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
239000002736 nonionic surfactant Substances 0.000 abstract 1
125000001453 quaternary ammonium group Chemical group 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1
230000008733 trauma Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Detergent Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT88114804T 1987-09-11 1988-09-09 Schutzmittel fuer augenzubereitungen. ATE74750T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9617387A	1987-09-11	1987-09-11
EP88114804A EP0306984B1 (de)	1987-09-11	1988-09-09	Schutzmittel für Augenzubereitungen

Publications (1)

Publication Number	Publication Date
ATE74750T1 true ATE74750T1 (de)	1992-05-15

Family

ID=22256043

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88114804T ATE74750T1 (de)	1987-09-11	1988-09-09	Schutzmittel fuer augenzubereitungen.

Country Status (17)

Country	Link
EP (1)	EP0306984B1 (de)
JP (1)	JPH0696542B2 (de)
KR (1)	KR950013754B1 (de)
AT (1)	ATE74750T1 (de)
AU (1)	AU626798B2 (de)
CA (1)	CA1328614C (de)
DE (1)	DE3870111D1 (de)
DK (1)	DK174702B1 (de)
FI (1)	FI94924C (de)
HK (1)	HK27894A (de)
HU (2)	HU199072B (de)
IE (1)	IE60717B1 (de)
IL (1)	IL87724A (de)
NO (1)	NO175404C (de)
NZ (1)	NZ226100A (de)
PH (1)	PH25422A (de)
ZA (1)	ZA886757B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5414011A (en) *	1987-09-11	1995-05-09	Syntex (U.S.A.) Inc.	Preservative system for ophthalmic formulations
ATE103182T1 (de) *	1989-09-21	1994-04-15	Ciba Vision Ag	Antimikrobielle zusammensetzungen.
IL95942A0 (en) *	1989-10-13	1991-07-18	Syntex Inc	Collagen-containing ophthalmic formulation
US5464609A (en) *	1990-03-16	1995-11-07	The Procter & Gamble Company	Use of ketorolac for treatment of oral diseases and conditions
ATE137967T1 (de) *	1990-03-16	1996-06-15	Procter & Gamble	Verwendung von ketorolac zur behandlung von periodontitis
AU653768B2 (en) *	1990-12-27	1994-10-13	Advanced Medical Optics, Inc.	Method and composition for disinfecting contact lenses
US5227152A (en) *	1991-04-09	1993-07-13	Merck Frosst Canada, Inc.	Radiopharmaceutical bacteriostats
US5306482A (en) *	1991-04-09	1994-04-26	Merck Frosst Canada, Inc.	Radiopharmaceutical bacteriostats
US5093105A (en) *	1991-04-09	1992-03-03	Merck Frosst Canada, Inc.	Radiopharmaceutical bacteriostats
JPH09506620A (ja) *	1993-12-17	1997-06-30	アルコン・ラボラトリーズ，インコーポレイテッド	非ステロイド抗炎症剤を含有する改良された眼内洗浄溶液
US5474985A (en) *	1993-12-22	1995-12-12	The Regents Of The University Of California	Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
ES2079320B1 (es) *	1994-05-17	1996-10-16	Cusi Lab	Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
WO1995033456A2 (en) *	1994-06-07	1995-12-14	Telor Ophthalmic Pharmaceuticals, Inc.	Reducing intraocular pressure using aryloxy- and aryl-acetic acids
AU3609795A (en) *	1994-10-10	1996-05-02	Novartis Ag	Ophthalmic and aural compositions containing diclofenac potassium
US5603929A (en) *	1994-11-16	1997-02-18	Alcon Laboratories, Inc.	Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
ATE215821T1 (de) *	1995-01-20	2002-04-15	Wakamoto Pharma Co Ltd	Entzündungshemmende augentropfen
US5674888A (en) *	1995-06-07	1997-10-07	University Of California	Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) *	1995-06-07	1997-02-04	Regents Of The University Of California	Methods for the cyto-protection of the trabecular meshwork
TW434023B (en) *	1995-09-18	2001-05-16	Novartis Ag	Preserved ophthalmic composition
JPH09278653A (ja) *	1996-04-05	1997-10-28	Santen Pharmaceut Co Ltd	網膜疾患治療剤
MX9701946A (es) *	1997-03-14	1998-04-30	Arturo Jimenez Bayardo	Solucion oftalmica transportadora.
DE19729879C2 (de) *	1997-07-11	1999-07-08	Mann Gerhard Chem Pharm Fab	Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
JP2006111636A (ja) *	1997-12-26	2006-04-27	Astellas Pharma Inc	徐放性医薬組成物
DE60039043D1 (de) *	1999-03-02	2008-07-10	Vitreo Retinal Technologies In	Mittel für intravitreale verabreichung zur behandlung oder vorbeugung von augenerkrankungen
DE19918324A1 (de) *	1999-04-22	2000-10-26	Mann Gerhard Chem Pharm Fab	Pharmazeutische Zusammensetzung wirksam gegen durch Bakterien, Viren, Pilze, Hefen und Protozoen verursachte Krankheitszustände
US20020035107A1 (en)	2000-06-20	2002-03-21	Stefan Henke	Highly concentrated stable meloxicam solutions
DE10161077A1 (de)	2001-12-12	2003-06-18	Boehringer Ingelheim Vetmed	Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en)	2002-10-25	2015-03-31	Boehringer Ingelheim Vetmedica Gmbh	Water-soluble meloxicam granules
WO2004064828A1 (ja)	2003-01-21	2004-08-05	Senju Pharmaceutical Co., Ltd.	２−アミノ−３−(４−ブロモベンゾイル)フェニル酢酸含有水性液剤
US8008338B2 (en)	2003-06-03	2011-08-30	Allergan, Inc.	Ketorolac tromethamine compositions for treating or preventing ocular pain
EP1654002B2 (de)	2003-08-07	2014-01-29	Allergan, Inc.	Zusammensetzungen zur abgabe von therapeutika in die augen
EP1568369A1 (de)	2004-02-23	2005-08-31	Boehringer Ingelheim Vetmedica Gmbh	Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
WO2005102303A2 (en) *	2004-04-21	2005-11-03	Advanced Ocular Systems Limited	Antiprostaglandins for the treatment of ocular pathologies
US9161905B2 (en) *	2005-01-12	2015-10-20	Ocular Research Of Boston, Inc.	Dry eye treatment
US9192571B2 (en)	2008-03-03	2015-11-24	Allergan, Inc.	Ketorolac tromethamine compositions for treating or preventing ocular pain
US9101529B2 (en)	2009-10-12	2015-08-11	Boehringer Ingelheim Vetmedica Gmbh	Containers for compositions comprising meloxicam
WO2011107150A1 (en)	2010-03-03	2011-09-09	Boehringer Ingelheim Vetmedica Gmbh	Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en)	2010-05-05	2017-10-24	Boehringer Ingelheim Vetmedica Gmbh	Low concentration meloxicam tablets
JP2013082682A (ja) *	2011-09-29	2013-05-09	Senju Pharmaceut Co Ltd	亜塩素酸塩を含有する水性製剤
CN110448530A (zh) *	2018-05-07	2019-11-15	北京蓝丹医药科技有限公司	一种氟比洛芬酯注射液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4087538A (en) *	1976-09-09	1978-05-02	Merck & Co., Inc.	Ophthalmic suspensions
DE3026402A1 (de) *	1980-07-11	1982-02-04	Syntex Corp., Palo Alto, Calif.	Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
AU573321B2 (en) *	1984-03-14	1988-06-02	Jerome Corbiere	Process for solubilizing active principles and pharmaceuticalcompositions thus obtained

1988
- 1988-09-09 JP JP63227343A patent/JPH0696542B2/ja not_active Expired - Lifetime
- 1988-09-09 KR KR1019880011664A patent/KR950013754B1/ko not_active Expired - Lifetime
- 1988-09-09 AT AT88114804T patent/ATE74750T1/de not_active IP Right Cessation
- 1988-09-09 DE DE8888114804T patent/DE3870111D1/de not_active Expired - Lifetime
- 1988-09-09 NZ NZ226100A patent/NZ226100A/en unknown
- 1988-09-09 EP EP88114804A patent/EP0306984B1/de not_active Expired - Lifetime
- 1988-09-09 NO NO884020A patent/NO175404C/no not_active IP Right Cessation
- 1988-09-09 ZA ZA886757A patent/ZA886757B/xx unknown
- 1988-09-09 FI FI884160A patent/FI94924C/fi not_active IP Right Cessation
- 1988-09-09 AU AU22042/88A patent/AU626798B2/en not_active Expired
- 1988-09-09 CA CA000576880A patent/CA1328614C/en not_active Expired - Lifetime
- 1988-09-09 IL IL87724A patent/IL87724A/xx not_active IP Right Cessation
- 1988-09-09 PH PH37525A patent/PH25422A/en unknown
- 1988-09-09 DK DK198805056A patent/DK174702B1/da not_active IP Right Cessation
- 1988-09-09 IE IE274088A patent/IE60717B1/en not_active IP Right Cessation
- 1988-09-09 HU HU884648A patent/HU199072B/hu unknown
1994
- 1994-03-24 HK HK278/94A patent/HK27894A/en not_active IP Right Cessation
- 1994-07-01 HU HU94P/P00006P patent/HU210610A9/hu unknown

Also Published As

Publication number	Publication date
EP0306984B1 (de)	1992-04-15
JPH01104023A (ja)	1989-04-21
IE882740L (en)	1989-03-11
HU210610A9 (en)	1995-05-29
AU2204288A (en)	1989-03-16
EP0306984A1 (de)	1989-03-15
HK27894A (en)	1994-03-31
ZA886757B (en)	1990-05-30
IL87724A0 (en)	1989-02-28
DK174702B1 (da)	2003-09-29
NO175404C (no)	1994-10-12
CA1328614C (en)	1994-04-19
NZ226100A (en)	1990-12-21
NO884020D0 (no)	1988-09-09
IE60717B1 (en)	1994-08-10
FI94924C (fi)	1995-11-27
AU626798B2 (en)	1992-08-13
DK505688D0 (da)	1988-09-09
DE3870111D1 (de)	1992-05-21
FI884160A0 (fi)	1988-09-09
KR950013754B1 (ko)	1995-11-15
KR890004691A (ko)	1989-05-09
IL87724A (en)	1992-01-15
JPH0696542B2 (ja)	1994-11-30
FI94924B (fi)	1995-08-15
NO884020L (no)	1989-03-13
HUT47839A (en)	1989-04-28
HU199072B (en)	1990-01-29
FI884160L (fi)	1989-03-12
DK505688A (da)	1989-03-12
NO175404B (no)	1994-07-04
PH25422A (en)	1991-07-01

Legal Events

Date	Code	Title
1992-09-15	UEP	Publication of translation of european patent specification
2001-12-15	EEIH	Change in the person of patent owner
2008-12-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
DE3870111D1 (de)	1992-05-21	Schutzmittel fuer augenzubereitungen.
CA2013188A1 (en)	1990-09-28	Preservative system for ophthalmic formulations
Göbbels et al.	1992	Corneal epithelial permeability of dry eyes before and after treatment with artificial tears
BR9407330A (pt)	1996-06-18	Solução oftálmica baseada em diclofenaco e tobramicina e formulação oftálmica
DE69333927D1 (de)	2006-01-12	Agglomerierte hydrophile Komplexe mit mehrphasigen Abgabeeigenschaften
ATE251458T1 (de)	2003-10-15	Nervenschutzende für auge von säugern unter anwendung von kaliumkanalblockern
DK0394211T3 (da)	1993-08-16	Forbedrede præparater med forøget vandopløselighed
DK1239774T3 (da)	2006-01-16	Apparat til behandling af öjensygdomme
DE69320405D1 (de)	1998-09-24	Ophthalmische Zusammensetzungen enthaltend als Wirkstoff Vitamin-E oder Ester davon
ES2048415T3 (es)	1994-03-16	Dispositivo de conformacion corneal automatico.
ATE227976T1 (de)	2002-12-15	Lösungen als träger für augenarzneien
ES2131373T3 (es)	1999-07-16	Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico.
EP1110554A4 (de)	2002-02-06	Medizinische zusammensetzungen zur behandlung von augenerkrankungen
AR004214A1 (es)	1998-11-04	Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
ES2173088T3 (es)	2002-10-16	Derivados de n-arilhidrazina utiles como agentes insecticidas y acaricidas.
DK0619296T3 (da)	1997-05-05	Phenylalkan(en)syrer med leukotrien B4-antagonistisk aktivitet
DK0410749T3 (da)	1994-11-14	Anthocyanidiner til behandling af ophthalmiske sygdomme
Millichamp et al.	1991	Comparison of flunixin meglumine and flurbiprofen for control of ocular irritative response in dogs
Falcon et al.	1979	Acycloguanosine: antiviral activity in the rabbit cornea
KR930702015A (ko)	1993-09-08	각막 장해 치료제
SU1357021A1 (ru)	1987-12-07	Средство, уменьшающее проницаемость капилл ров, снижающее агрегацию тромбоцитов, дл лечени внутриглазных кровоизли ний
ATE143264T1 (de)	1996-10-15	Zusammensetzung zur intraokularen benetzung und zur präservierung herauspräparierter augäpfel
Gelatt	1981	Multifocal ocular histoplasmosis in a dog and cat: by RM Gwin, Torrence A. Makley, Jr., Milton Wyman, and Kathryn Werling. J Am Vet Med Assoc 176: 638–642, 1980
Obituary	1957	BRITISH JOURNAL
EIM et al.	1992	EVALUATION OF GENTA MICIN SULFATE IN AQUEOUS HUMOR OF DONKEYS FOLLOWING ITS ADMINISTRATION